Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells

British Journal of Cancer, Published online: 11 March 2024; doi:10.1038/s41416-024-02649-zInhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells

Source: British Journal of Cancer - March 11, 2024 Category: Cancer & Oncology Authors: Anxo Rio-Vilari ño Aiora Cenigaonandia-Campillo Ana Garc ía-Bautista Pedro A. Mateos-G ómez Marina I. Schlaepfer Laura del Puerto-Nevado Oscar Aguilera Laura Garc ía-García Carlos Galeano Irene de Miguel Juana Serrano-L ópez Natalia Ba ños Mar ía Source Type: research